Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.52 is in line with its 5-year average of 2.59, around the middle of its 5-year range (1.67–3.82).
As of the fiscal period ended Tuesday, June 30, 2026. 23.57% above its 12-month average of 2.04.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.52.
QUICK RATIO (ACID-TEST)
2.52
QUICK RATIO (ACID-TEST) AVG TTM
2.04
QUICK RATIO (ACID-TEST) AVG 3Y
2.22
QUICK RATIO (ACID-TEST) AVG 5Y
2.59
QUICK RATIO (ACID-TEST) AVG 10Y
2.79
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.57%
CURRENT VS 3Y AVG
+13.78%
CURRENT VS 5Y AVG
-2.51%
CURRENT VS 10Y AVG
-9.64%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 519 covered companies
CURRENT VS SECTOR MEDIAN
-15.69%
vs the sector median at left
Establishment Labs Holdings Inc.
Market Cap
$1.99B
Quick Ratio (Acid-Test)
2.52
TTM Avg
2.04
3Y Avg
2.22
5Y Avg
2.59
Market Cap
$1.99B
Quick Ratio (Acid-Test)
15.08
TTM Avg
9.38
3Y Avg
7.12
5Y Avg
8.07
Market Cap
$1.99B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
Market Cap
$2.02B
Quick Ratio (Acid-Test)
4.97
TTM Avg
4.46
3Y Avg
5.74
5Y Avg
7.97
Market Cap
$2.05B
Quick Ratio (Acid-Test)
2.29
TTM Avg
2.30
3Y Avg
3.09
5Y Avg
3.45
Market Cap
$2.07B
Quick Ratio (Acid-Test)
6.16
TTM Avg
5.39
3Y Avg
6.60
5Y Avg
7.52
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.99B | 2.52 | 2.04 | 2.22 | 2.59 |
| Immunome, Inc. (IMNM)vs › | $1.99B | 15.08 | 9.38 | 7.12 | 8.07 |
| Absci Corporation (ABSI)vs › | $1.99B | 10.63 | 5.62 | 5.25 | 6.00 |
| AxoGen, Inc. (AXGN)vs › | $2.02B | 5.04 | 2.74 | 2.74 | 3.55 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 4.97 | 4.46 | 5.74 | 7.97 |
| Alvotech (ALVO)vs › | $2.04B | 0.96 | 1.42 | 1.06 | 1.08 |
| Azenta, Inc. (AZTA)vs › | $2.05B | 2.21 | 3.08 | 5.65 | 4.53 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.05B | 2.29 | 2.30 | 3.09 | 3.45 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.07B | 6.16 | 5.39 | 6.60 | 7.52 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 7.14 | 4.14 | 3.11 | 3.56 |
Quick Ratio
2.52
Excludes inventory
Current Ratio
3.84
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.52 |
| 2026-03-31 | 1.91 |
| 2025-12-31 | 2.00 |
| 2025-09-30 | 2.10 |
| 2025-06-30 | 1.67 |
| 2025-03-31 | 2.05 |
| 2024-12-31 | 2.41 |
| 2024-09-30 | 2.29 |
| 2024-06-30 | 2.91 |
| 2024-03-31 | 2.73 |
| 2023-12-31 | 1.67 |
| 2023-09-30 | 2.33 |
| 2023-06-30 | 3.53 |
| 2023-03-31 | 2.31 |
| 2022-12-31 | 2.91 |
| 2022-09-30 | 3.29 |
| 2022-06-30 | 3.74 |
| 2022-03-31 | 2.23 |
| 2021-12-31 | 2.66 |
| 2021-09-30 | 3.22 |
| 2021-06-30 | 3.82 |
| 2021-03-31 | 4.27 |
| 2020-12-31 | 4.21 |
| 2020-09-30 | 5.24 |
| 2020-06-30 | 5.22 |
| 2020-03-31 | 5.45 |
| 2019-12-31 | 2.89 |
| 2019-09-30 | 3.52 |
| 2019-06-30 | 2.70 |
| 2019-03-31 | 4.10 |
| 2018-12-31 | 4.54 |
| 2018-09-30 | 6.02 |
| 2018-06-30 | 1.71 |
| 2018-03-31 | 1.38 |
| 2017-12-31 | 0.46 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
